Divineus Light with Lidocaine 1.1ML/Syringe 1 Syringe/Box
Divineus Deep with Lidocaine 1.1ML/Syringe 1 Syringe/Box
Divineus Volume with Lidocaine 1.1ML/Syringe 1 Syringe/Box
Powder 1g*2 vials / Solution 10ml*2 vials / Calming Ampoule 10ml*2 vials...
No RSS feed added
Since the launch of botulinum toxin type A Meditoxin® in 2006 (trade name: Neuronox®, Siax®, Botulift®, Cunox®, Tonytox® and Meditoxin®), Medytox has shown a dramatic growth. Medytox reached nearly 40% of market share in Korea since 2009 and is expected to increase even further with various indications being included. The global botulinum toxin market continues to grow and is expected to further expand to not only medical aesthetics market but also therapeutic market. Medytox is stunning the world with high market share in the global botulinum market.
With the goal of penetrating to the US and Europe, we plan to exceed 10% of the market share in the global market along with the launch of the currently developing new type botulinum toxin products.
In the future, Medytox will grow as the leader of the biopharmaceutical industry by challenging ourselves with passion for the global market.
Innotox us the world’s first liquid injectable form of botulinum Toxin type A approved by KFDA in South Korea, 2013. Allergan, the Botox manufacturer, made an exclusive license agreement to market Innotox worldwide, excluding Korea and Japan.
Neuramis is made in Korea with Korean KFDA & GMP Certification. Neuramis Deep lidocaine can be used for facial volume enhancement and deep wrinkles. it is 100% hyaluronic acid dermal filler. It is made by Medytox in South Korea.
Neuramis is made in Korea with Korean KFDA & GMP Certification. Neuramis Volume with lidocaine can be used for facial volume enhancement and facial contours such as chin, cheek and nose. it is 100% hyaluronic acid dermal filler. It is made by Medytox in South Korea.